Cargando…

Multiple m(6)A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis

BACKGROUND: Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death in the world. N(6)-methyladenosine (m(6)A) RNA methylation is dynamically regulated by m(6)A RNA methylation modulators (“writer,” “eraser,” and “reader” proteins), which are associated with cancer occ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Nanfang, Qin, Sanyu, Zhang, Xuemei, Bo, Xiaotong, Liu, Zhengchun, Tan, Chao, Wen, Guiqiong, Jiang, Haixing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047390/ https://www.ncbi.nlm.nih.gov/pubmed/32111180 http://dx.doi.org/10.1186/s12885-020-6638-5

Ejemplares similares

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

m(6)A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2021)

Effect of m(6)A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
por: Wang, Jiawu, et al.
Publicado: (2020)

m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer
por: Chen, Mei, et al.
Publicado: (2019)

Exploration of the Role of m(6) A RNA Methylation Regulators in Malignant Progression and Clinical Prognosis of Ovarian Cancer
por: Wei, Qinglv, et al.
Publicado: (2021)

Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2013)

ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022)

m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer
por: Zhang, Cheng, et al.
Publicado: (2021)

Profiles of m(6)A RNA methylation regulators for the prognosis of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma
por: Zhang, Yingai, et al.
Publicado: (2019)

Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis
por: Yamamoto, Yosuke, et al.
Publicado: (2020)

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
por: Liu, Jinfang, et al.
Publicado: (2021)

Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2015)

The Cancer Genome Atlas (TCGA) based m(6)A methylation-related genes predict prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2020)

M(6)A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunotherapy Response in Hepatocellular Carcinoma
por: Liu, Fei, et al.
Publicado: (2022)

PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma
por: Ge, Sijia, et al.
Publicado: (2022)

DNA methylation-mediated high expression of CCDC50 correlates with poor prognosis and hepatocellular carcinoma progression
por: Li, Chunhong, et al.
Publicado: (2023)

The Identification of Critical m(6)A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
por: Xu, Jiaju, et al.
Publicado: (2020)

m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis
por: Jiang, Xiaohan, et al.
Publicado: (2023)

m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
por: Chai, Rui-Chao, et al.
Publicado: (2019)

CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
por: Yu, Qianle, et al.
Publicado: (2020)

Association of Mental Health-Related Proteins DAXX, DRD3, and DISC1 With the Progression and Prognosis of Chondrosarcoma
por: He, Lile, et al.
Publicado: (2019)

Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients
por: Hu, Zhicheng, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) RNA methylation regulators are associated with clinical prognosis in hepatocellular carcinoma
por: Li, Gao, et al.
Publicado: (2020)

WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
por: Yuan, Xuesong, et al.
Publicado: (2023)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023)

Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia
por: Hua, Jing, et al.
Publicado: (2022)

eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway
por: Sun, Liping, et al.
Publicado: (2021)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

MicroRNA-32 Regulates Development and Progression of Hepatocellular Carcinoma by Targeting ADAMTS9 and Affects Its Prognosis
por: Li, Shengmian, et al.
Publicado: (2018)

N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma
por: Zhou, Kexiang, et al.
Publicado: (2022)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Coagulation factor VII and malignant progression of hepatocellular carcinoma
por: Chen, K-D, et al.
Publicado: (2016)

EPRS1 correlates with malignant progression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2023)

Fibulin-2 Facilitates Malignant Progression of Hepatocellular Carcinoma
por: Hu, Xinyan, et al.
Publicado: (2023)

The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2020)

Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma
por: Yin, Tengfei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ds9rc91a2jrg2as3gkk8bgm4bn